688166.SS
688166.SS
CNE100003PR1
BRIGHTGENE BIO-MEDICAL TECHNOLO
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
14.61B EUR
15.26B EUR
20.51B EUR
Enterprise Value
16.23B EUR
16.51B EUR
22.2B EUR
Valuation Multiples
Trailing P/E
145.78x
226.57x
668.85x
Forward P/E
56.83x
--
--
Price to Sales
10.71x
11.59x
16.92x
Price to Book
4.78x
5x
8.1x
EV/Revenue
11.9x
12.54x
18.32x
EV/EBITDA
60.56x
104.93x
299.69x
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
-1.1%
-0.42%
-1.15%
ende